Palonosetron in the management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day chemotherapy.
about
Comparative evaluation of triplet antiemetic schedule versus doublet antiemetic schedule in chemotherapy-induced emesis in head and neck cancer patients.Combination of Palonosetron, Aprepitant, and Dexamethasone Effectively Controls Chemotherapy-induced Nausea and Vomiting in Patients Treated with Concomitant Temozolomide and Radiotherapy: Results of a Prospective Study.Analysis of Dietary Intake during Consecutive-Day Chemotherapy for Bone and Soft-Tissue Sarcomas.
P2860
Palonosetron in the management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day chemotherapy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Palonosetron in the management ...... ing multiple-day chemotherapy.
@ast
Palonosetron in the management ...... ing multiple-day chemotherapy.
@en
Palonosetron in the management ...... ing multiple-day chemotherapy.
@nl
type
label
Palonosetron in the management ...... ing multiple-day chemotherapy.
@ast
Palonosetron in the management ...... ing multiple-day chemotherapy.
@en
Palonosetron in the management ...... ing multiple-day chemotherapy.
@nl
prefLabel
Palonosetron in the management ...... ing multiple-day chemotherapy.
@ast
Palonosetron in the management ...... ing multiple-day chemotherapy.
@en
Palonosetron in the management ...... ing multiple-day chemotherapy.
@nl
P2860
P356
P1476
Palonosetron in the management ...... ing multiple-day chemotherapy.
@en
P2093
Joseph Bubalo
Mary Lou Affronti
P2860
P304
P356
10.2147/CMAR.S68102
P407
P577
2014-09-05T00:00:00Z